CU6 clarity pharmaceuticals ltd

CU6 - Media and Industry News, page-417

  1. 1,066 Posts.
    lightbulb Created with Sketch. 1240

    My view on the UBS Report's Clarity related comments!

    Isn’t it a bit ironic that on the one hand, the analysts talk up the Telix pipeline and highlight the potential catalytic effects that some of their candidate products that are still in phase 1 may have, while in the same report, they join in dismissing a competitor on grounds including that they (the competitor) is ‘late’ in the game! This, at at a point when this ‘late’ comer has a candidate product that is in phase 3!


    Does coming in late mean you are going to find nothing left! Will cancers stop developing, now that Telix is in town? If so, why then does Telix even has a thing called a pipeline? A pipeline to what or where, if getting there first is all that matters?

    Perhaps Chris (Telix CEO) was cornered and hadn't had time to prepare, but the Analysts had time to read through all of this!


    Anyway, here is what the Telix CEO said a few months ago in March, when asked about about competition in general (Telix is competing with others), as well as Clarity in particular! Start at 18:40.

    Last edited by ttppxx: 24/08/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$3.54
Change
0.130(3.81%)
Mkt cap ! $1.148B
Open High Low Value Volume
$3.54 $3.74 $3.42 $11.14M 3.113M

Buyers (Bids)

No. Vol. Price($)
11 3739 $3.53
 

Sellers (Offers)

Price($) Vol. No.
$3.54 790 7
View Market Depth
Last trade - 12.47pm 17/07/2025 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.